Immunologic Approaches to Composite Tissue Allograft

Journal of Hand Surgery

Volumn 32, Issue 7, 2007, Pages 1072-1085

  Taieb, Aurèle ^a   Clavijo Alvarez, Julio A ^a   Hamad, Giselle G ^a   Lee, W P Andrew ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft; composite; immunology; review; tissue

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALLOGRAFT; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHIMERA; COMPOSITE GRAFT; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CHIMERISM; HISTOCOMPATIBILITY TESTING; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; TISSUE TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548444639     PISSN: 03635023     EISSN: 15316564     Source Type: Journal    
DOI: 10.1016/j.jhsa.2007.06.013     Document Type: Review

References (117)

1. Goldsby R.A., Kindt T.J., Osborne B.A., and Kuby J. Immunology. 5th ed (2002), W. H. Freeman
2. Barth R., Counce S., Smith P., and Snell G.D. Strong and weak histocompatibility gene differences in mice and their role in the rejection of homografts of tumors and skin. Ann Surg 144 (1956) 198-204
3. Laylor R., Cannella L., Simpson E., and Dazzi F. Minor histocompatibility antigens and stem cell transplantation. Vox Sang 87 Suppl 2 (2004) 11-14
4. Ceppellini R., Mattiuz P.L., Scudeller G., and Visetti M. Experimental allotransplantation in man. I. The role of the HL-A system in different genetic combinations. Transplant Proc 1 (1969) 385-389
5. Pescovitz M.D., Sachs D.H., Lunney J.K., and Hsu S.M. Localization of class II MHC antigens on porcine renal vascular endothelium. Transplantation 37 (1984) 627-630
6. Bourget J.L., Mathes D.W., Nielsen G.P., Randolph M.A., Tanabe Y.N., Ferrara V.R., et al. Tolerance to musculoskeletal allografts with transient lymphocyte chimerism in miniature swine. Transplantation 71 (2001) 851-856
7. Lee W.P., Rubin J.P., Bourget J.L., Cober S.R., Randolph M.A., Nielsen G.P., et al. Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens. Plast Reconstr Surg 107 (2001) 1482-1490 discussion 1491-1492
8. Mathes D.W., Randolph M.A., and Lee W.P. Strategies for tolerance induction to composite tissue allografts. Microsurgery 20 (2000) 448-452
9. Mathes D.W., Randolph M.A., Solari M.G., Nazzal J.A., Nielsen G.P., Arn J.S., et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 75 (2003) 25-31
10. Jones N.F. Concerns about human hand transplantation in the 21st century. J Hand Surg 27A (2002) 771-787
11. Mori M., Beatty P.G., Graves M., Boucher K.M., and Milford E.L. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 64 (1997) 1017-1027
12. Prabhune K.A., Gorantla V.S., Maldonado C., Perez-Abadia G., Barker J.H., and Ildstad S.T. Mixed allogeneic chimerism and tolerance to composite tissue allografts. Microsurgery 20 (2000) 441-447
13. Monaco A.P. Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation 75 9 Suppl (2003) 13S-16S
14. Wood K.J. Passenger leukocytes and microchimerism: what role in tolerance induction?. Transplantation 75 9 Suppl (2003) 17S-20S
15. Starzl T.E., Demetris A.J., Trucco M., Ramos H., Zeevi A., Rudert W.A., et al. Systemic chimerism in human female recipients of male livers. Lancet 340 (1992) 876-877
16. Starzl T.E., Demetris A.J., Murase N., Ildstad S., Ricordi C., and Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 339 (1992) 1579-1582
17. Starzl T.E., Demetris A.J., Trucco M., Murase N., Ricordi C., Ildstad S., et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 17 (1993) 1127-1152
18. Ferrand C., Perruche S., Robinet E., Martens A., Tiberghien P., and Saas P. How should chimerism be decoded?. Transplantation 75 9 Suppl (2003) 50S-54S
19. Wekerle T., and Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 52 (2001) 353-370
20. Siemionow M., and Ozer K. Advances in composite tissue allograft transplantation as related to the hand and upper extremity. J Hand Surg 27A (2002) 565-580
21. Main J.M., and Prehn R.T. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 15 (1955) 1023-1029
22. Ildstad S.T., and Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307 (1984) 168-170
23. Sharabi Y., and Sachs D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169 (1989) 493-502
24. Game D.S., and Lechler R.I. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10 (2002) 101-108
25. Abbas A., and Lichtman A. Basic immunology: Functions and disorders of the immune system. Sidcup. 2nd ed (2003), W.B. Saunders 560
26. Lechler R.I., and Batchelor J.R. Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J Exp Med 156 (1982) 1835-1841
27. Lechler R.I., and Batchelor J.R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 155 (1982) 31-41
28. Lafferty K.J., Cooley M.A., Woolnough J., and Walker K.Z. Thyroid allograft immunogenicity is reduced after a period in organ culture. Science 188 (1975) 259-261
29. Ko S., Deiwick A., Jager M.D., Dinkel A., Rohde F., Fischer R., et al. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med 5 (1999) 1292-1297
30. Fabre J.W., and Morris P.J. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 14 (1972) 608-617
31. Wood K.J., Evins J., and Morris P.J. Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. Transplantation 39 (1985) 56-62
32. Josien R., Heslan M., Brouard S., Soulillou J.P., and Cuturi M.C. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. Blood 92 (1998) 4539-4544
33. Zimmermann F.A., Davies H.S., Knoll P.P., Gokel J.M., and Schmidt T. Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft. Transplantation 37 (1984) 406-410
34. Qian S., Demetris A.J., Murase N., Rao A.S., Fung J.J., and Starzl T.E. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 19 (1994) 916-924
35. Sriwatanawongsa V., Davies H.S., and Calne R.Y. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1 (1995) 428-432
36. Sriwatanawongsa V., Davies H.F., and Calne R.Y. Successful retransplantation of rat liver grafts. Transplantation 59 (1995) 908-910
37. Rifle G., and Mousson C. Donor-derived hematopoietic cells in organ transplantation: a major step toward allograft tolerance?. Transplantation 75 9 Suppl (2003) 3S-7S
38. Ishida H., Kawai T., Tanabe K., Hayasaka Y., Yasuo M., Toma H., et al. Status of microchimerism in recipients 15 years after living related kidney transplantation. Transplantation 62 (1996) 126-128
39. Triulzi D.J., and Nalesnik M.A. Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion 41 (2001) 419-426
40. Hisanaga M., Hundrieser J., Boker K., Uthoff K., Raddatz G., Wahlers T., et al. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation 61 (1996) 40-45
41. Schlitt H.J., Hundrieser J., Ringe B., and Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 330 (1994) 646-647
42. Schlitt H.J., Hundrieser J., Hisanaga M., Uthoff K., Karck M., Wahlers T., et al. Patterns of donor-type microchimerism after heart transplantation. Lancet 343 (1994) 1469-1471
43. Hamano K., Rawsthorne M.A., Bushell A.R., Morris P.J., and Wood K.J. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 62 (1996) 856-860
44. Elwood E.T., Larsen C.P., Maurer D.H., Routenberg K.L., Neylan J.F., Whelchel J.D., et al. Microchimerism and rejection in clinical transplantation. Lancet 349 (1997) 1358-1360
45. Wood K., and Sachs D.H. Chimerism and transplantation tolerance: cause and effect. Immunol Today 17 (1996) 584-587 discussion 588
46. Sivasai K.S., Alevy Y.G., Duffy B.F., Brennan D.C., Singer G.G., Shenoy S., et al. Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation 64 (1997) 427-432
47. Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102 (1945) 400-401
48. Anderson D., Billingham R.E., Lampkin G.H., and Medawar P.B. The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 5 (1951) 379-397
49. Billingham R.E., Lampkin G.H., Medawar P.B., and Williams H.L. Tolerance to homografts, twin diagnosis, and the freemartin condition in cattle. Heredity 6 (1952) 201-212
50. Wekerle T., Blaha P., Koporc Z., Bigenzahn S., Pusch M., and Muehlbacher F. Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: central versus peripheral tolerance. Transplantation 75 9 Suppl (2003) 21S-25S
51. Sykes M. Mixed chimerism and transplant tolerance. Immunity 14 (2001) 417-424
52. Singer A., Hathcock K.S., and Hodes R.J. Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J Exp Med 153 (1981) 1286-1301
53. Ildstad S.T., Wren S.M., Bluestone J.A., Barbieri S.A., Stephany D., and Sachs D.H. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2-B10). J Immunol 136 (1986) 28-33
54. Pelot M.R., Pearson D.A., Swenson K., Zhao G., Sachs J., Yang Y.G., et al. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant 5 (1999) 133-143
55. Markees T.G., Phillips N.E., Gordon E.J., Noelle R.J., Shultz L.D., Mordes J.P., et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. J Clin Invest 101 (1998) 2446-2455
56. Wekerle T., Sayegh M.H., Hill J., Zhao Y., Chandraker A., Swenson K.G., et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 187 (1998) 2037-2044
57. Wekerle T., Sayegh M.H., Ito H., Hill J., Chandraker A., Pearson D.A., et al. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 68 (1999) 1348-1355
58. Wekerle T., and Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation 68 (1999) 459-467
59. Nikolic B., and Sykes M. Clonal deletion as a mechanism of transplantation tolerance. J Heart Lung Transplant 15 (1996) 1171-1178
60. Tomita Y., Khan A., and Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 153 (1994) 1087-1098
61. Foster R.D., Fan L., Neipp M., Kaufman C., McCalmont T., Ascher N., et al. Donor-specific tolerance induction in composite tissue allografts. Am J Surg 176 (1998) 418-421
62. Mathes D.W., Randolph M.A., Bourget J.L., Nielsen G.P., Ferrera V.R., Arn J.S., et al. Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft. Transplantation 73 (2002) 1880-1885
63. Wekerle T., and Sykes M. Induction of tolerance. Surgery 135 (2004) 359-364
64. Huang C.A., Fuchimoto Y., Scheier-Dolberg R., Murphy M.C., Neville Jr. D.M., and Sachs D.H. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 105 (2000) 173-181
65. Fuchimoto Y., Huang C.A., Yamada K., Shimizu A., Kitamura H., Colvin R.B., et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 105 (2000) 1779-1789
66. Kawai T., Cosimi A.B., Colvin R.B., Powelson J., Eason J., Kozlowski T., et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59 (1995) 256-262
67. Spitzer T.R., Delmonico F., Tolkoff-Rubin N., McAfee S., Sackstein R., Saidman S., et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68 (1999) 480-484
68. Millan M.T., Shizuru J.A., Hoffmann P., Dejbakhsh-Jones S., Scandling J.D., Grumet F.C., et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73 (2002) 1386-1391
69. Sayegh M.H., Fine N.A., Smith J.L., Rennke H.G., Milford E.L., and Tilney N.L. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114 (1991) 954-955
70. Jacobsen N., Taaning E., Ladefoged J., Kristensen J.K., and Pedersen F.K. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 343 (1994) 800
71. Dey B., Sykes M., and Spitzer T.R. Outcomes of recipients of both bone marrow and solid organ transplants. A review. Medicine (Baltimore) 77 (1998) 355-369
72. Kean L.S., Adams A.B., Strobert E., Hendrix R., Gangappa S., Jones T.R., et al. Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant 7 (2007) 320-335
73. Suzuki H., Patel N., Matthews M., DelRossi A.J., Doolin E.J., and Hewitt C.W. Vascularized bone marrow transplantation: a new surgical approach using isolated femoral bone/bone marrow. J Surg Res 89 (2000) 176-183
74. Talmor M., Steinman R.M., Codner M.A., Chen M., Harper A.D., Witmer-Pack M.D., et al. Bone marrow-derived chimerism in non-irradiated, cyclosporin-treated rats receiving microvascularized limb transplants: evidence for donor-derived dendritic cells in recipient lymphoid tissues. Immunology 86 (1995) 448-455
75. Siemionow M.Z., Izycki D.M., and Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation 76 (2003) 1662-1668
76. Siemionow M., Oke R., Ozer K., Izycki D., and Prajapati R. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol. J Hand Surg 27A (2002) 1095-1103
77. Janczewska S., Ziolkowska A., Durlik M., Olszewski W.L., and Lukomska B. Fast lymphoid reconstitution after vascularized bone marrow transplantation in lethally irradiated rats. Transplantation 68 (1999) 201-209
78. Durlik M., Lukomska B., Ziolkowska H., Namyslowski A., Janczewska S., Cybulska E., et al. Microchimerism following allogeneic vascularized bone marrow transplantation-its possible role in induction of posttransplantation tolerance. Ann Transplant 3 (1998) 24-26
79. Ramsamooj R., Llull R., Black K.S., and Hewitt C.W. Composite tissue allografts in rats: IV. Graft-versus-host disease in recipients of vascularized bone marrow transplants. Plast Reconstr Surg 104 (1999) 1365-1371
80. Hewitt C.W., Ramsamooj R., Patel M.P., Yazdi B., Achauer B.M., and Black K.S. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation 50 (1990) 766-772
81. Tai C.Y., Strande L.F., Eydelman R., Sheng X., VanTran J.L., Matthews M.S., et al. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant. Transplantation 77 (2004) 316-319
82. Dubernard J.M., Owen E., Lefrancois N., Petruzzo P., Martin X., Dawahra M., et al. First human hand transplantation. Case report. Transpl Int 13 Suppl 1 (2000) S521-S524
83. Dubernard J.M., Owen E., Herzberg G., Martin X., Guigal V., Dawahra M., et al. [The first transplantation of a hand in humans. Early results]. Chirurgie 124 (1999) 358-365 discussion 365-367
84. Dubernard J.M., Owen E., Herzberg G., Lanzetta M., Martin X., Kapila H., et al. Human hand allograft: report on first 6 months. Lancet 353 (1999) 1315-1320
85. Hewitt C.W., Black K.S., Dowdy S.F., Gonzalez G.A., Achauer B.M., Martin D.C., et al. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation 41 (1986) 39-43
86. Bach F.H., Albertini R.J., Joo P., Anderson J.L., and Bortin M.M. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2 (1968) 1364-1366
87. Waldmann H. The new immunosuppression. Curr Opin Chem Biol 7 (2003) 476-480
88. Wells A.D., Walsh M.C., Bluestone J.A., and Turka L.A. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 108 (2001) 895-903
89. Sho M., Sandner S.E., Najafian N., Salama A.D., Dong V., Yamada A., et al. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. Ann Surg 236 (2002) 667-675
90. Li X.C., Strom T.B., Turka L.A., and Wells A.D. T cell death and transplantation tolerance. Immunity 14 (2001) 407-416
91. Snanoudj R., de Preneuf H., Creput C., Arzouk N., Deroure B., Beaudreuil S., et al. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int 19 (2006) 693-704
92. Viola A., Schroeder S., Sakakibara Y., and Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283 (1999) 680-682
93. Ridge J.P., Di Rosa F., and Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393 (1998) 474-478
94. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., and Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393 (1998) 478-480
95. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., and Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393 (1998) 480-483
96. Grewal I.S., and Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16 (1998) 111-135
97. Grewal I.S., and Flavell R.A. The CD40 ligand. At the center of the immune universe?. Immunol Res 16 (1997) 59-70
98. Bluestone J.A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2 (1995) 555-559
99. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., et al. The CD40 antigen and its ligand. Annu Rev Immunol 12 (1994) 881-922
100. Kirk A.D., Burkly L.C., Batty D.S., Baumgartner R.E., Berning J.D., Buchanan K., et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 5 (1999) 686-693
101. Iwakoshi N.N., Mordes J.P., Markees T.G., Phillips N.E., Rossini A.A., and Greiner D.L. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 164 (2000) 512-521
102. Gudmundsdottir H., and Turka L.A. T cell costimulatory blockade: new therapies for transplant rejection. J Am Soc Nephrol 10 (1999) 1356-1365
103. Larsen C.P., Elwood E.T., Alexander D.Z., Ritchie S.C., Hendrix R., Tucker-Burden C., et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381 (1996) 434-438
104. Kirk A.D., Harlan D.M., Armstrong N.N., Davis T.A., Dong Y., Gray G.S., et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 94 (1997) 8789-8794
105. Iwasaki N., Gohda T., Yoshioka C., Murakami M., Inobe M., Minami A., et al. Feasibility of immunosuppression in composite tissue allografts by systemic administration of CTLA4Ig. Transplantation 73 (2002) 334-340
106. Kawai T., Andrews D., Colvin R.B., Sachs D.H., and Cosimi A.B. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 6 (2000) 114
107. Elster E.A., Blair P.J., and Kirk A.D. Potential of costimulation-based therapies for composite tissue allotransplantation. Microsurgery 20 (2000) 430-434
108. Heidecke C.D., Hancock W.W., Jakobs F., Westerholt S., Sewzcik T., Deusch K., et al. TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survival. Transplant Proc 25 1 Pt 1 (1993) 540-542
109. Alcover A., and Alarcon B. Internalization and intracellular fate of TCR-CD3 complexes. Crit Rev Immunol 20 (2000) 325-346
110. Ozer K., Izycki D., Zielinski M., and Siemionow M. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols. Microsurgery 24 (2004) 248-254
111. Heidecke C.D., Hancock W.W., Jakobs F., Zantl N., Kurrle R., Westerholt S., et al. alpha/beta-T cell receptor-directed therapy in rat cardiac allograft recipients. Treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection. Transplantation 59 (1995) 78-84
112. Kampinga J., Schuurman H.J., Pol G.H., Bartels H., Broekhuizen R., Vaessen L.M., et al. Vascular thymus transplantation in rats. Technique, morphology, and function. Transplantation 50 (1990) 669-678
113. Klimczak A., Agaoglu G., Carnevale K.A., and Siemionow M. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II. Ann Plast Surg 57 (2006) 422-430
114. Ozkaynak E., Wang L., Goodearl A., McDonald K., Qin S., O'Keefe T., et al. Programmed death-1 targeting can promote allograft survival. J Immunol 169 (2002) 6453-6546
115. Curry A.J., Chikwe J., Smith X.G., Cai M., Schwarz H., Bradley J.A., et al. OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation 78 (2004) 807-814
116. Demirci G., Amanullah F., Kewalaramani R., Yagita H., Strom T.B., Sayegh M.H., et al. Critical role of OX40 in CD28 and CD154-independent rejection. J Immunol 172 (2004) 1691-1698
117. Cho H.R., Kwon B., Yagita H., La S., Lee E.A., Kim J.E., et al. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival. Transpl Int 17 (2004) 351-361